Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A pilot study of adalimumab in infliximab-allergic patients.

A pilot study of adalimumab in infliximab-allergic patients. Inflamm Bowel Dis. 2004 Jul; 10(4):333-8.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.